Personalized blood transfusion plan for heart surgery patients
Part of Blood & lymphatic clinical trials.
This study tests whether a personalized plan for when to give blood transfusions works better than the usual approach in people having heart surgery with a heart-lung machine. The goal is to find a safer and more effective way to manage transfusions during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and scheduled for heart surgery that uses a heart-lung machine, like bypass or valve surgery.
- Your surgical risk is moderate to high (for example, a score of 3% or more on the EuroSCORE).
- You are willing to receive blood products and can be assigned to different transfusion levels.
- You are not someone who refuses blood (like a Jehovah's Witness), do not have severe anemia (hemoglobin less than 8), and are not on dialysis.
- You are not pregnant or breastfeeding, and you are not in another trial that affects how blood transfusions are used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how much donated blood (blood products) is needed for younger adults during heart surgery that uses a heart-lung machine. It may help doctors choose safer, more appropriate blood-saving plans for people like you.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
This trial tests a blood management strategy to help people with anemia who are having coronary artery bypass surgery (CABG). If you qualify, you may receive a treatment to improve your blood counts before surgery, which could reduce the need for transfusions.
This trial tests whether giving blood transfusions sooner or later during surgery affects recovery for patients with low hemoglobin. It compares using a liberal (higher) threshold to give blood versus a more restrictive (lower) threshold.
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hear when a new Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.